MARY GEROW: Open Payments
NPI 1558145805 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,634 in 139 payments from 20 companies in 2025. Trend: 2023 $407 · 2024 $2,603 · 2025 $2,634
Food & beverage: $2,634
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $351 |
| ABBVIE INC. | 14 | $270 |
| Teva Pharmaceuticals USA, Inc. | 16 | $244 |
| Neurocrine BioSciences, Inc. | 13 | $234 |
| Alkermes, Inc. | 14 | $207 |
| Otsuka America Pharmaceutical, Inc. | 10 | $200 |
| Lundbeck LLC | 8 | $169 |
| Collegium Pharmaceutical, Inc. | 8 | $151 |
| Tris Pharma Inc | 8 | $147 |
| Vanda Pharmaceuticals Inc. | 8 | $139 |
Products named: Auvelity, REXULTI, VRAYLAR, INGREZZA, ARISTADA, AUSTEDO XR, Jornay PM, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
